Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Mon 23 Dec 2002, 8:47 Zarara - Reviewed Preliminary Results For The Year
ZARARA ENERGY LIMITED                                                           
(Registration number: 1895/001078/06)                                           
(Incorporated in the Republic of South Africa)                                  
Share code: ZRR ISIN: ZAE000033080                                              
("Zarara" or "the Company")                                                     
REVIEWED PRELIMINARY RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2002               
Issued: 27 430 900 Ordinary shares of 5 cents each                              
Weighted average number of shares used in earnings calculations: 2002 - 27 430  
900 (2001 - 26 122 254)                                                         
Abridged consolidated income statement                                          
                                        Reviewed            Audited             
                                        Year ended          Year ended          
                                        30 Sept 2002        30 Sept 2001        
R`000               R`000               
Revenue                                 159,913             29,959              
Operating loss                          (22,582)            (120,258)           
Amortisation of goodwill                357                 -                   
Loss before investment and                                                      
interest income                         (22,225)            (120,258)           
Income from investment                  -                   1,130               
Net interest received                   1,955               6,477               
Loss before taxation                    (20,270)            (112,651)           
Taxation                                4,283               (485)               
Net loss after taxation                 (24,553)            (113,136)           
Outside shareholder`s interest          (6,075)             1,484               
Net loss for the year                   (30,628)            (111,652)           
Determination of headline loss                                                  
Net loss per income statement           (30,628)            (111,652)           
Profit on disposal of investments       (2,265)             (636)               
Profit on sale of property, plant                                               
and equipment                           (74)                (522)               
Impairment of property, plant and                                               
equipment                               11,619              -                   
Impairment of investments and loan -                        48,271              
Write (up)/down of goodwill             (5,680)             35,130              
Headline loss                           (27,028)            (29,409)            
Headline loss per share (cents)         (98)                (112)               
Attributable loss per share (cents)     (112)               (427)-              
Summarised cash flow                                                            
Cash generated by operating                                                     
activities                              27,024              49,338              
Cash utilised in investing                                                      
activities                              (36,288)            (19,915)            
Cash inflow/(outflow) from                                                      
financing activities                    10,808              (13,291)            
Net cash inflow                         1,544               16,132              
Abridged consolidated balance sheet                                             
                                        Reviewed            Audited             
                                        At                  At                  
30 Sept 2002        30 Sept 2001        
                                        R`000               R`000               
Assets                                                                          
Fixed assets                            37,767              18,577              
Negative goodwill                       (1,327)             -                   
Deferred taxation                       775                 177                 
Investment and loans                    16,429              24,263              
Non-current assets                      53,644              43,017              
Current assets                          91,682              89,909              
Total assets                            145,326             132,926             
Equity and liabilities                                                          
Capital and reserves                    79,113              107,828             
Outside shareholder`s interest          9,693               305                 
Long term liabilities                   13,444              3,508               
Current liabilities                     43,076              21,285              
Total equity and liabilities            145,326             32,926              
Abridged statement of changes in equity                                         
Share capital and premium                                                       
Opening balance                         352,831             364,236             
Capital reduction                       -                   (11,405)            
352,831             352,831             
Non-distributable reserves                                                      
Opening balance                         2,868               3,446               
Pre-acquisition reserves                1,913               -                   
Translation of foreign currency         -                   (578)               
Transfer to distributable reserves      (640)               -                   
                                        4,141               2,868               
Distributable reserves                                                          
Opening balance                         (247,871)           (136,797)           
Transfer from non-distributable                                                 
reserve                                 640                 578                 
Net loss                                (30,628)            (111,652)           
(277,859)           (247,871)           
Total equity                            79,113              107,828             
Net asset value per share (cents)       288                 393                 
SEGMENTAL REPORT                                                                
Gross      Operating     Total                         
                         revenue    (loss)/profit assets                        
2002                                                                            
Market segment                                                                  
Energy                   92         (28,789)      43,818                        
Maritime                 10,216     1,991         -                             
Properties               8,697      (10,621)      8,667                         
Biotechnology            140,908    14,837        92,841                        
159,913    (22,582)      145,326                       
Geographical segment                                                            
Republic of South Africa 159,821    (11,152)      132,947                       
Foreign countries        92         (11,430)      12,379                        
159,913    (22,582)      145,326                       
2001                                                                            
Market segment                                                                  
Energy                   -          (121,146)     98,964                        
Maritime                 16,817     195           6,528                         
Property                 13,142     693           27,434                        
Biotechnology            -          -             -                             
                         29,959     (120,258)     132,926                       
Geographical segment                                                            
Republic of South Africa 29,959     (89,661)      112990                        
Foreign countries        -          (30,597)      19936                         
                         29,959     (120,258)     132,926                       
REVIEW OF OPERATIONS                                                            
Shortly after the Annual General Meeting held on 22nd April 2002 the board of   
the company was restructured. The directors of the company believe that it is in
the best interest of Zarara Shareholders for the company to realise to its best 
advantage, its interests in the various assets held. Consequently it has sold a 
number of its assets for cash and shares thereby enhancing shareholder value.   
-The directors intend recommending to the shareholders that the remaining assets
be realised with a view to ultimately winding up and liquidating the company.   
Payments to shareholders, as appropriate, will be made as and when the situation
warrants such payments. During the financial year the company sold its interest 
in Mawenzi Vulindlela Maritime (Pty) Ltd and Stepstone Investments (Pty) Ltd for
a consideration of R4 150 000. Subsequent to the year-end it has sold tributing 
rights and claims to Sub Nigel Gold Mining Company Ltd for one million fully    
paid ordinary shares of no par value in Sub Nigel Gold Mining Company Ltd. It   
has also sold Caribbean Estates (Pty) Ltd for a consideration of R500 000.      
-Shareholders of the company are referred to the announcement dated 13th        
December 2002 of a proposed sale of SA Bioproducts Holdings (Pty) Ltd and a     
proposed share repurchase.                                                      
-The company`s lawyers have been instructed to deliver a plea in the New        
Republic Bank damages matter and to apply for a trial date.                     
Accounting Policies                                                             
The accounting policies conform with the Statements of South African Generally  
Accepted Accounting Practice and have been consistently applied.                
The financial statements are prepared on a going concern basis and reflect      
historical costs.                                                               
Reviewed Report                                                                 
Results have been reviewed by the auditors of the company, Deloitte & Touche    
Chartered Accountants (SA). The review report, which is unqualified, includes an
emphasis of matter raised which states: "Without qualifying our opinion, we draw
attention to Review of Operations in the preliminary financial information,     
which indicates that the directors intend recommending to the shareholders that 
the remaining assets of the company be realised with a view to ultimately       
winding-up and liquidating the company. The preliminary financial information   
has been prepared on the basis that the company continues as a going concern and
does not take into account the adjustments that may be necessary for the        
realisation of assets and settlement of liabilities on the liquidation basis."  
This report is available for inspection at the company`s registered office.     
Capital Expenditure                                                             
SA Bioproducts (Pty) Ltd embarked during the year on a strategy to broaden its  
range of products by the expansion of its plant to enable it to produce         
threonine and other small volume, high value amino acids.  The expenditure on   
plant expansion amounted to R31,0 million.  Further expenditure of R18,1 million
has been approved by the board of directors of SA Bioproducts (Pty) Ltd which   
will be funded from loans and internal resources.                               
Loans and Overdrafts                                                            
SA Bioproducts (Pty) Ltd has a R10 million overdraft facility with Nedbank      
Limited which has not been accessed.  Security comprises first cession of the   
company`s debtors. In addition, subsequent to the year end, that company entered
into a loan agreement with BAE Systems PLC for the provision of a long term loan
facility in the sum of $2 million. Security for the loan comprises a deed of    
suretyship by Val Des Bois Investments (Pty) Ltd, a group company, and a        
notarial bond passed over the fixed assets of the company.                      
Lease commitments                                                               
The lease commitments payable within one year amount to R977 000 and thereafter 
R2 639 000.                                                                     
By order of the board                                                           
WJDI Scott:  Chairman                                                           
LM Carroll: Chief Operating Officer and Company Secretary                       
-Non Executive Directors :   WJDI Scott (Chairman), HC Buitendag,  NE Moon,  RB 
Shead                                                                           
Registered office  - 18 Rivonia Road, Illovo, Sandton. 2196                     
Transfer Secretaries - Computershare Services Ltd, 70 Marshall Street,          
Johannesburg 2001                                                               
Date: 23/12/2002 07:08:30 AM Produced by the JSE SENS Department
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: